Next Article in Journal
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events
Previous Article in Journal
Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report
 
 
Article

Article Versions Notes

Curr. Oncol. 2021, 28(3), 2150-2172; https://doi.org/10.3390/curroncol28030200
Action Date Notes Link
article xml file uploaded 11 June 2021 09:10 CEST Original file -
article xml uploaded. 11 June 2021 09:10 CEST Update https://www.mdpi.com/1718-7729/28/3/200/xml
article pdf uploaded. 11 June 2021 09:10 CEST Version of Record https://www.mdpi.com/1718-7729/28/3/200/pdf
article supplementary file uploaded. 11 June 2021 09:10 CEST - https://www.mdpi.com/1718-7729/28/3/200#supplementary
article html file updated 11 June 2021 09:12 CEST Original file -
article html file updated 26 July 2022 23:51 CEST Update https://www.mdpi.com/1718-7729/28/3/200/html
Back to TopTop